J Korean Assoc Oral Maxillofac Surg.  2018 Apr;44(2):43-51. 10.5125/jkaoms.2018.44.2.43.

Non-invasive different modalities of treatment for temporomandibular disorders: review of literature

• Abouelhuda AM
• khalifa AK
• Kim YK
• Hegazy SA

• KMID: 2410579
• DOI: http://doi.org/10.5125/jkaoms.2018.44.2.43

Abstract

Temporomandibular disorders (TMDs) are diseases that affect the temporomandibular joint and supporting structures. The goal of treatment for TMDs is elimination or reduction of pain and return to normal temporomandibular joint function. Initial treatment for TMDs is non-invasive and conservative, not surgical. Oral and maxillofacial surgeons should fully understand and actively care about non-invasive treatments for TMDs. The purpose of this study is to review the validity and outcomes of non-invasive and surgical treatment modalities for TMDs.

Keyword

Temporomandibular disorders; Therapeutics

MeSH Terms

Oral and Maxillofacial Surgeons
Temporomandibular Joint
Temporomandibular Joint Disorders*

Figure

• 

  Fig. 1 Diagram showing the protocol and staging of treatment for different presentations of temporomandibular disorder.

Reference

1. Carlson CR, Okeson JP, Falace DA, Nitz AJ, Curran SL, Anderson D. Comparison of psychologic and physiologic functioning between patients with masticatory muscle pain and matched controls. J Orofac Pain. 1993; 7:15–22. PMID: 8467294.

2. Wang X, Yang Z, Zhang W, Yi X, Liang C, Li X. Efficacy evaluation of low-level laser therapy on temporomandibular disorder. Hua Xi Kou Qiang Yi Xue Za Zhi. 2011; 29:393–395. PMID: 21932661.

3. Sipahi A, Satilmis T, Basa S. Comparative study in patients with symptomatic internal derangements of the temporomandibular joint: analgesic outcomes of arthrocentesis with or without intraarticular morphine and tramadol. Br J Oral Maxillofac Surg. 2015; 53:316–320. PMID: 25623934.

4. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009; 32:1–32. PMID: 19400724.

5. Cairns BE, Mann MK, Mok E, Dong XD, Svensson P. Diclofenac exerts local anesthetic-like actions on rat masseter muscle afferent fibers. Brain Res. 2008; 1194:56–64. PMID: 18199427.

6. Dina OA, Green PG, Levine JD. Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience. 2008; 152:521–525. PMID: 18280048.

7. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 1998; 41:1591–1602. PMID: 9751091.

8. Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, et al. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther. 1999; 65:336–347. PMID: 10096266.

9. Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain. 1997; 11:139–146. PMID: 10332320.

10. Gottesdiener K, Mehlisch DR, Huntington M, Yuan WY, Brown P, Gertz B, et al. Efficacy and tolerability of the specific cyclooxygenase-2 inhibitor DFP compared with naproxen sodium in patients with postoperative dental pain. Clin Ther. 1999; 21:1301–1312. PMID: 10485502.

11. Ta LE, Dionne RA. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebocontrolled comparison of celecoxib to naproxen. Pain. 2004; 111:13–21. PMID: 15327804.

12. Yap AU, Tan KB, Chua EK, Tan HH. Depression and somatization in patients with temporomandibular disorders. J Prosthet Dent. 2002; 88:479–484. PMID: 12473996.

13. Falisi G, Rastelli C, Panti F, Maglione H, Quezada Arcega R. Psychotropic drugs and bruxism. Expert Opin Drug Saf. 2014; 13:1319–1326. PMID: 25195948.

14. Chang JP, Wu CC, Su KP. A case of venlafaxine-induced bruxism alleviated by duloxetine substitution. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35:307. PMID: 21111016.

15. Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. J Orofac Pain. 2002; 16:64–70. PMID: 11889661.

16. Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, Ambrosano GM, de Barbosa JR. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio. 2003; 21:221–225. PMID: 12889679.

17. Hersh EV, Balasubramaniam R, Pinto A. Pharmacologic management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am. 2008; 20:197–210. PMID: 18343325.

18. Ownby SL, Fortuno LV, Au AY, Grzanna MW, Rashmir-Raven AM, Frondoza CG. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. J Inflamm (Lond). 2014; 11:8. PMID: 24678847.

19. Christiansen BA, Bhatti S, Goudarzi R, Emami S. Management of osteoarthritis with avocado/soybean unsaponifiables. Cartilage. 2015; 6:30–44. PMID: 25621100.

20. Halon A, Donizy P, Dziegala M, Dobrakowski R, Simon K. Tissue laser biostimulation promotes post-extraction neoangiogenesis in HIV-infected patients. Lasers Med Sci. 2015; 30:701–706. PMID: 23917415.

21. Ahrari F, Madani AS, Ghafouri ZS, Tunér J. The efficacy of lowlevel laser therapy for the treatment of myogenous temporomandibular joint disorder. Lasers Med Sci. 2014; 29:551–557. PMID: 23318917.

22. Bradley P. The maxillofacial region: recent research and clinical practice in low intensity laser therapy. In : Simunovic Z, editor. Lasers in medicine and dentistry: basic science and up-to-date clinical application of low energy-level laser therapy--LLLT. Rijeka: European Medical Laser Association;2000. p. 385–402.

23. Kulekcioglu S, Sivrioglu K, Ozcan O, Parlak M. Effectiveness of low-level laser therapy in temporomandibular disorder. Scand J Rheumatol. 2003; 32:114–118. PMID: 12737331.

24. Coombe AR, Ho CT, Darendeliler MA, Hunter N, Philips JR, Chapple CC, et al. The effects of low level laser irradiation on osteoblastic cells. Clin Orthod Res. 2001; 4:3–14. PMID: 11553080.

25. Pinheiro AL, Cavalcanti ET, Pinheiro TI, Alves MJ, Miranda ER, De Quevedo AS, et al. Low-level laser therapy is an important tool to treat disorders of the maxillofacial region. J Clin Laser Med Surg. 1998; 16:223–226. PMID: 9796491.

26. Mannheimer JS. Therapeutic modalities. In : Kraus SL, editor. TMJ disorders management of the craniomandibular complex. New York: Churchill Livingstone;1988. p. 311–337.

27. Jankelson B, Radke JC. The myo-monitor: its use and abuse (I). Quintessence Int Dent Dig. 1978; 9:47–52.

28. Pereira LJ, Gavião MB, Bonjardim LR, Castelo PM, Andrade Ada S. Ultrasonography and electromyography of masticatory muscles in a group of adolescents with signs and symptoms of TMD. J Clin Pediatr Dent. 2006; 30:314–319. PMID: 16937858.

29. Ariji Y, Katsumata A, Hiraiwa Y, Izumi M, Sakuma S, Shimizu M, et al. Masseter muscle sonographic features as indices for evaluating efficacy of massage treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110:517–526. PMID: 20868996.

30. El Fatih IA, Ibrahim AI, El Laithi A. Efficacy of physiotherapy and intraoral splint in the management of temporomandibular disorders. J Saudi Dent. 2004; 16:16–20.

31. Esposito CJ, Veal SJ, Farman AG. Alleviation of myofascial pain with ultrasonic therapy. J Prosthet Dent. 1984; 51:106–108. PMID: 6583380.

32. Santuzzi CH, Gonçalves WLS, Rocha SS, Castro MEC, Gouvea SA, Abreu GR. Effects of cryotherapy, transcutaneous electrical stimulation and their combination on femoral nerve electrical activity in rats. Rev Bras Fisioter. 2008; 12:441–446.

33. Deshpande RG, Mhatre S. TMJ disorders and occlusal splint therapy: a review. Int J Dent Clin. 2010; 2:22–29.

34. Gray RJ, Davies SJ. Occlusal splints and temporomandibular disorders: why, when, how? Dent Update. 2001; 28:194–199. PMID: 11476035.

35. Winocur E, Gavish A, Emodi-Perlman A, Halachmi M, Eli I. Hypnorelaxation as treatment for myofascial pain disorder: a comparative study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93:429–434. PMID: 12029281.

36. Al-Ani MZ, Davies SJ, Gray RJ, Sloan P, Glenny AM. Stabilisation splint therapy for temporomandibular pain dysfunction syndrome. Cochrane Database Syst Rev. 2004; (1):CD002778. PMID: 14973990.

37. Qvintus V, Suominen AL, Huttunen J, Raustia A, Ylöstalo P, Sipilä K. Efficacy of stabilisation splint treatment on facial pain: 1-year follow-up. J Oral Rehabil. 2015; 42:439–446. PMID: 25644634.

38. Triantaffilidou K, Venetis G, Bika O. Efficacy of hyaluronic acid injections in patients with osteoarthritis of the temporomandibular joint. A comparative study. J Craniofac Surg. 2013; 24:2006–2009. PMID: 24220392.

39. Alpaslan GH, Alpaslan C. Efficacy of temporomandibular joint arthrocentesis with and without injection of sodium hyaluronate in treatment of internal derangements. J Oral Maxillofac Surg. 2001; 59:613–618. PMID: 11381380.

40. Long X, Chen G, Cheng AH, Cheng Y, Deng M, Cai H, et al. A randomized controlled trial of superior and inferior temporomandibular joint space injection with hyaluronic acid in treatment of anterior disc displacement without reduction. J Oral Maxillofac Surg. 2009; 67:357–361. PMID: 19138610.

41. Alpaslan C, Bilgihan A, Alpaslan GH, Güner B, Ozgür Yis M, Erbaş D. Effect of arthrocentesis and sodium hyaluronate injection on nitrite, nitrate, and thiobarbituric acid-reactive substance levels in the synovial fluid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89:686–690. PMID: 10846121.

42. Sato S, Kawamura H. Changes in condylar mobility and radiographic alterations after treatment in patients with non-reducing disc displacement of the temporomandibular joint. Dentomaxillofac Radiol. 2006; 35:289–294. PMID: 16798928.

43. Sato S, Nasu F, Motegi K. Analysis of kinesiograph recordings and masticatory efficiency after treatment of non-reducing disk displacement of the temporomandibular joint. J Oral Rehabil. 2003; 30:708–713. PMID: 12791156.

44. Sato S, Nasu F, Motegi K. Analysis of post-treatment electromyographs in patients with non-reducing disc displacement of the temporomandibular joint. J Oral Rehabil. 2002; 29:1126–1130. PMID: 12453269.

45. Basterzi Y, Sari A, Demirkan F, Unal S, Arslan E. Intraarticular hyaluronic acid injection for the treatment of reducing and nonreducing disc displacement of the temporomandibular joint. Ann Plast Surg. 2009; 62:265–267. PMID: 19240522.

46. Yeung RWK, Chow RLK, Samman N, Chiu K. Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102:453–461. PMID: 16997111.

47. Meunier FA, Schiavo G, Molgó J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris. 2002; 96:105–113. PMID: 11755789.

48. The Wealthy Dentist [Internet]. Tiburon (CA): The Wealthy Dentist;cited 2018 Feb 6. Available from: http://thewealthydentist.com/.

49. Emara AS, Faramawey MI, Hassaan MA, Hakam MM. Botulinum toxin injection for management of temporomandibular joint clicking. Int J Oral Maxillofac Surg. 2013; 42:759–764. PMID: 23538215.

50. Arinci A, Güven E, Yazar M, Başaran K, Keklik B. Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint. Kulak Burun Bogaz Ihtis Derg. 2009; 19:122–129. PMID: 19857189.

51. Kim HS, Yun PY, Kim YK. A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg. 2016; 38:5. PMID: 26855937.

52. Moon YM, Kim YJ, Kim MK, Kim SG, Kweon H, Kim TW. Early effect of Botox-A injection into the masseter muscle of rats: functional and histological evaluation. Maxillofac Plast Reconstr Surg. 2015; 37:46. PMID: 26753166.

53. Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study. Br J Oral Maxillofac Surg. 2013; 51:199–205. PMID: 22871559.

54. Park SY, Park YW, Ji YJ, Park SW, Kim SG. Effects of a botulinum toxin type A injection on the masseter muscle: an animal model study. Maxillofac Plast Reconstr Surg. 2015; 37:10. PMID: 25938091.

55. Song PC, Schwartz J, Blitzer A. The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Oral Dis. 2007; 13:253–260. PMID: 17448205.

56. Monje-Gil F, Nitzan D, González-Garcia R. Temporomandibular joint arthrocentesis. Review of the literature. Med Oral Patol Oral Cir Bucal. 2012; 17:e575–e581. PMID: 22322493.

57. Cömert Kiliç S, Güngörmüş M, Sümbüllü MA. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis alone in the treatment of temporomandibular joint osteoarthritis? A randomized clinical trial. J Oral Maxillofac Surg. 2015; 73:1473–1483. PMID: 25976690.

58. Davis CL, Kaminishi RM, Marshall MW. Arthroscopic surgery for treatment of closed lock. J Oral Maxillofac Surg. 1991; 49:704–707. PMID: 2056368.

59. Stringer DE, Park CM. Single-cannula technique for operative arthroscopy using holmium:YAG laser. J Oral Maxillofac Surg. 2012; 70:49–50. PMID: 21982691.

60. McCain JP, Hossameldin RH. Advanced arthroscopy of the temporomandibular joint. Atlas Oral Maxillofac Surg Clin North Am. 2011; 19:145–167. PMID: 21878249.

61. Moon SY, Chung H. Ultra-thin rigid diagnostic and therapeutic arthroscopy during arthrocentesis: development and preliminary clinical findings. Maxillofac Plast Reconstr Surg. 2015; 37:17. PMID: 26191518.

62. Indresano AT. Surgical arthroscopy as the preferred treatment for internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 2001; 59:308–312. PMID: 11243614.

63. Machoň V, Sedý J, Klíma K, Hirjak D, Foltán R. Arthroscopic lysis and lavage in patients with temporomandibular anterior disc displacement without reduction. Int J Oral Maxillofac Surg. 2012; 41:109–113. PMID: 21885248.

64. Smolka W, Iizuka T. Arthroscopic lysis and lavage in different stages of internal derangement of the temporomandibular joint: correlation of preoperative staging to arthroscopic findings and treatment outcome. J Oral Maxillofac Surg. 2005; 63:471–478. PMID: 15789318.

65. Smolka W, Yanai C, Smolka K, Iizuka T. Efficiency of arthroscopic lysis and lavage for internal derangement of the temporomandibular joint correlated with Wilkes classification. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106:317–323. PMID: 18226569.

66. McCain JP, Sanders B, Koslin MG, Quinn JH, Peters PB, Indresano AT. Temporomandibular joint arthroscopy: a 6-year multicenter retrospective study of 4,831 joints. J Oral Maxillofac Surg. 1992; 50:926–930. PMID: 1506966.

67. Murakami KI, Tsuboi Y, Bessho K, Yokoe Y, Nishida M, Iizuka T. Outcome of arthroscopic surgery to the temporomandibular joint correlates with stage of internal derangement: five-year follow-up study. Br J Oral Maxillofac Surg. 1998; 36:30–34. PMID: 9578253.